Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 541K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Gonzalez, A. D. Articles by Filmus, J. Search for Related Content PubMed PubMed Citation Articles by Gonzalez, A. D. Articles by Filmus, J. Social Bookmarking                            What's this?

© The Rockefeller University Press, 0021-9525/1998//1407 $5.00
The Journal of Cell Biology, Volume 141, Number 6, , 1998 1407-1414

OCI-5/GPC3, a Glypican Encoded by a Gene That Is Mutated in the Simpson-Golabi-Behmel Overgrowth Syndrome, Induces Apoptosis in a Cell Line–specific Manner

Alfonso Dueñas Gonzalez^*,, Mitsunori Kaya^*,, Wen Shi^*,, Howard Song^*,, Joseph R. Testa, Linda Z. Penn^||,, and Jorge Filmus^*,

^* Division of Cancer Biology Research, Sunnybrook Health Science Centre, Toronto, Ontario M4N 3M5, Canada; Department of Medical Biophysics, University of Toronto, Ontario M5G 2M9, Canada; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111; and ^|| Ontario Cancer Institute, Ontario M5G 2M9, Canada

OCI-5/GPC3 is a member of the glypican family. Glypicans are heparan sulfate proteoglycans that are bound to the cell surface through a glycosyl-phosphatidylinositol anchor. It has recently been shown that the OCI-5/GPC3 gene is mutated in patients with the Simpson-Golabi-Behmel Syndrome (SGBS), an X-linked disorder characterized by pre- and postnatal overgrowth and various visceral and skeletal dysmorphisms. Some of these dysmorphisms could be the result of deficient growth inhibition or apoptosis in certain cell types during development. Here we present evidence indicating that OCI-5/GPC3 induces apoptosis in cell lines derived from mesothelioma (II14) and breast cancer (MCF-7). This induction, however, is cell line specific since it is not observed in NIH 3T3 fibroblasts or HT-29 colorectal tumor cells. We also show that the apoptosis-inducing activity in II14 and MCF-7 cells requires the anchoring of OCI-5/GPC3 to the cell membrane. The glycosaminoglycan chains, on the other hand, are not required. MCF-7 cells can be rescued from OCI-5/GPC3–induced cell death by insulin-like growth factor 2. This factor has been implicated in Beckwith-Wiedemann, an overgrowth syndrome that has many similarities with SGBS. The discovery that OCI-5/GPC3 is able to induce apoptosis in a cell line– specific manner provides an insight into the mechanism that, at least in part, is responsible for the phenotype of SGBS patients.

Abbreviations used in this paper: GAG, glycosaminoglycan; GPI, glycosylphosphatidylinositol; GPC, glypican; HA, hemagglutinin A; IGF2, insulin-like growth factor 2; PARP, poly ADP ribose polymerase; SGBS, Simpson-Golabi-Behmel Syndrome.

Address all correspondence to Dr. Jorge Filmus, Division of Cancer Biology Research, S-218 Research Building, Sunnybrook Health Science Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. Tel.: (416) 480-6100 ext. 3350. Fax: (416) 480-5703. E-mail: filmus{at}srcl.sunnybrook.utoronto.ca.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

• Wittrup, A., Zhang, S.-H., ten Dam, G. B., van Kuppevelt, T. H., Bengtson, P., Johansson, M., Welch, J., Morgelin, M., Belting, M. (2009). ScFv Antibody-induced Translocation of Cell-surface Heparan Sulfate Proteoglycan to Endocytic Vesicles: EVIDENCE FOR HEPARAN SULFATE EPITOPE SPECIFICITY AND ROLE OF BOTH SYNDECAN AND GLYPICAN. J. Biol. Chem. 284: 32959-32967 [Abstract] [Full Text]  
• Ishiguro, T., Sugimoto, M., Kinoshita, Y., Miyazaki, Y., Nakano, K., Tsunoda, H., Sugo, I., Ohizumi, I., Aburatani, H., Hamakubo, T., Kodama, T., Tsuchiya, M., Yamada-Okabe, H. (2008). Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer. Cancer Res. 68: 9832-9838 [Abstract] [Full Text]  
• Scott, R H, Stiller, C A, Walker, L, Rahman, N (2006). Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J. Med. Genet. 43: 705-715 [Abstract] [Full Text]  
• Selleck, S. B. (2006). Shedding Light on the Distinct Functions of Proteoglycans. Sci Signal 2006: pe17-pe17 [Abstract] [Full Text]  
• Capurro, M. I., Shi, W., Sandal, S., Filmus, J. (2005). Processing by Convertases Is Not Required for Glypican-3-induced Stimulation of Hepatocellular Carcinoma Growth. J. Biol. Chem. 280: 41201-41206 [Abstract] [Full Text]  
• Capurro, M. I., Xiang, Y.-Y., Lobe, C., Filmus, J. (2005). Glypican-3 Promotes the Growth of Hepatocellular Carcinoma by Stimulating Canonical Wnt Signaling. Cancer Res. 65: 6245-6254 [Abstract] [Full Text]  
• Helvering, L.M., Adrian, M.D., Geiser, A.G., Estrem, S.T., Wei, T., Huang, S., Chen, P., Dow, E.R., Calley, J. N., Dodge, J.A., Grese, T.A., Jones, S.A., Halladay, D.L., Miles, R.R., Onyia, J.E., Ma, Y.L., Sato, M., Bryant, H.U. (2005). Differential Effects of Estrogen and Raloxifene on Messenger RNA and Matrix Metalloproteinase 2 Activity in the Rat Uterus. Biol. Reprod. 72: 830-841 [Abstract] [Full Text]  
• Song, H. H., Shi, W., Xiang, Y.-Y., Filmus, J. (2005). The Loss of Glypican-3 Induces Alterations in Wnt Signaling. J. Biol. Chem. 280: 2116-2125 [Abstract] [Full Text]  
• Nakatsura, T., Kageshita, T., Ito, S., Wakamatsu, K., Monji, M., Ikuta, Y., Senju, S., Ono, T., Nishimura, Y. (2004). Identification of Glypican-3 as a Novel Tumor Marker for Melanoma. Clin. Cancer Res. 10: 6612-6621 [Abstract] [Full Text]  
• Davies, E. J., Blackhall, F. H., Shanks, J. H., David, G., McGown, A. T., Swindell, R., Slade, R. J., Martin-Hirsch, P., Gallagher, J. T., Jayson, G. C. (2004). Distribution and Clinical Significance of Heparan Sulfate Proteoglycans in Ovarian Cancer. Clin. Cancer Res. 10: 5178-5186 [Abstract] [Full Text]  
• Kim, H., Xu, G.-L., Borczuk, A. C., Busch, S., Filmus, J., Capurro, M., Brody, J. S., Lange, J., D'Armiento, J. M., Rothman, P. B., Powell, C. A. (2003). The Heparan Sulfate Proteoglycan GPC3 Is a Potential Lung Tumor Suppressor. Am. J. Respir. Cell Mol. Bio. 29: 694-701 [Abstract] [Full Text]  
• De Cat, B., Muyldermans, S.-Y., Coomans, C., Degeest, G., Vanderschueren, B., Creemers, J., Biemar, F., Peers, B., David, G. (2003). Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements. JCB 163: 625-635 [Abstract] [Full Text]  
• Zhu, Z-W, Friess, H, Wang, L, Abou-Shady, M, Zimmermann, A, Lander, A D, Korc, M, Kleeff, J, Buchler, M W (2001). Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut 48: 558-564 [Abstract] [Full Text]  
• Bandtlow, C. E., Zimmermann, D. R. (2000). Proteoglycans in the Developing Brain: New Conceptual Insights for Old Proteins. Physiol. Rev. 80: 1267-1290 [Abstract] [Full Text]  
• Veugelers, M., Cat, B. D., Muyldermans, S. Y., Reekmans, G., Delande, N., Frints, S., Legius, E., Fryns, J.-P., Schrander-Stumpel, C., Weidle, B., Magdalena, N., David, G. (2000). Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. Hum Mol Genet 9: 1321-1328 [Abstract] [Full Text]  
• Lander, A. D., Selleck, S. B. (2000). The Elusive Functions of Proteoglycans: In Vivo Veritas. JCB 148: 227-232 [Full Text]  
• Veugelers, M., De Cat, B., Ceulemans, H., Bruystens, A.-M., Coomans, C., Durr, J., Vermeesch, J., Marynen, P., David, G. (1999). Glypican-6, a New Member of the Glypican Family of Cell Surface Heparan Sulfate Proteoglycans. J. Biol. Chem. 274: 26968-26977 [Abstract] [Full Text]  
• Cano-Gauci, D. F., Song, H. H., Yang, H., McKerlie, C., Choo, B., Shi, W., Pullano, R., Piscione, T. D., Grisaru, S., Soon, S., Sedlackova, L., Tanswell, A. K., Mak, T. W., Yeger, H., Lockwood, G. A., Rosenblum, N. D., Filmus, J. (1999). Glypican-3-Deficient Mice Exhibit Developmental Overgrowth and Some of the Abnormalities Typical of Simpson-Golabi-Behmel Syndrome. JCB 146: 255-264 [Abstract] [Full Text]  
• Lin, H., Huber, R., Schlessinger, D., Morin, P. J. (1999). Frequent Silencing of the GPC3 Gene in Ovarian Cancer Cell Lines. Cancer Res. 59: 807-810 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents